SLC5A2 and type 2 diabetes mellitus: To further investigate the correlation between SGLT2 inhibitors and IR, we measured the levels of circulating ADI, a known insulin sensitizer and cardio-protective adipokine22, 23, 24, and TNFα, an inflammatory marker at pre- and post-treatment in our patients with T2DM.